{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:37:26Z","timestamp":1781246246354,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.nbd.2023.106385","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:12:34Z","timestamp":1702926754000},"page":"106385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation \u2013 A 5-year follow-up [11C]PIB-PET study"],"prefix":"10.1016","volume":"190","author":[{"given":"Elina","family":"Pietil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"Snellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Tuisku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Viitanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha O.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Ekblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nbd.2023.106385_bb0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00259-009-1174-1","article-title":"Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data","volume":"36","author":"Aalto","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.wnl.0000167607.63000.38","article-title":"A total score for the CERAD neuropsychological battery","volume":"65","author":"Chandler","year":"2005","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.nbd.2023.106385_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc16-2001","article-title":"Insulin resistance predicts cognitive decline: an 11-year follow-up of a nationally representative adult population sample","volume":"40","author":"Ekblad","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.nbd.2023.106385_bb2000","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/dc15-1588","article-title":"Type 2diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia","volume":"39","author":"Chatterjee","year":"2016","journal-title":"Diabetes Care"},{"issue":"13","key":"10.1016\/j.nbd.2023.106385_bb0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005214","article-title":"Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation","volume":"90","author":"Ekblad","year":"2018","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0025","article-title":"Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer\u2019s disease in non-demented adults","volume":"13","author":"Ennis","year":"2021","journal-title":"Alzheimers Dement. Diagn. Assess Dis. Monit."},{"issue":"2","key":"10.1016\/j.nbd.2023.106385_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-180297","article-title":"Metabolic syndrome and amyloid accumulation in the aging brain","volume":"65","author":"Gomez","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"14","key":"10.1016\/j.nbd.2023.106385_bb0035","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2017.3090","article-title":"Association between midlife vascular risk factors and estimated brain amyloid deposition","volume":"317","author":"Gottesman","year":"2017","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.nbd.2023.106385_bb0040","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106385_bb0045","series-title":"Methodology Report: Health 2000 Survey. B26\/2008","author":"Heistaro","year":"2008"},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0050","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-160110","article-title":"Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer\u2019s disease and reduced memory function in at-risk healthy middle-aged adults","volume":"52","author":"Hoscheidt","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.nbd.2023.106385_bb0055","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1194\/jlr.M400250-JLR200","article-title":"Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample","volume":"45","author":"J\u00e4nis","year":"2004","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.nbd.2023.106385_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical Spectrum","volume":"79","author":"Jansen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2023.106385_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fninf.2020.00003","article-title":"Magia: robust automated image processing and kinetic modeling toolbox for PET neuroinformatics","volume":"14","author":"Karjalainen","year":"2020","journal-title":"Front. Neuroinform."},{"issue":"6","key":"10.1016\/j.nbd.2023.106385_bb0070","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/oby.23761","article-title":"Insulin resistance, cognition, and Alzheimer disease","volume":"31","author":"Kim","year":"2023","journal-title":"Obesity."},{"issue":"10","key":"10.1016\/j.nbd.2023.106385_bb0075","first-page":"1556","article-title":"Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease","volume":"2005;62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09577-4","article-title":"Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults","volume":"7","author":"Laws","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106385_bb0085","article-title":"Cerebrovascular insulin receptors are defective in Alzheimer\u2019s disease","author":"Leclerc","year":"2022","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.nbd.2023.106385_bb0090","first-page":"1959","article-title":"Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2023.106385_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"EBioMedicine."},{"issue":"7","key":"10.1016\/j.nbd.2023.106385_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.1016\/j.nbd.2023.106385_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac243","article-title":"Differential regulation of insulin signaling by monomeric and oligomeric amyloid beta-peptide","author":"Molina-Fern\u00e1ndez","year":"2022","journal-title":"Brain Commun."},{"issue":"9","key":"10.1016\/j.nbd.2023.106385_bb0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/en.2012-1661","article-title":"Insulin has multiple antiamyloidogenic effects on human neuronal cells","volume":"154","author":"Pandini","year":"2013","journal-title":"Endocrinology."},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0120","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes."},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0125","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-200145","article-title":"Association of peripheral insulin resistance and other markers of type 2 diabetes mellitus with brain amyloid deposition in healthy individuals at risk of dementia","volume":"76","author":"Pekkala","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.nbd.2023.106385_bb0130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0135","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s12035-019-01858-5","article-title":"Alzheimer\u2019s disease and diabetes: insulin signaling as the bridge linking two pathologies","volume":"57","author":"Shieh","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106385_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neurobiolaging.2017.05.008","article-title":"Applicability of [(11)C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model","volume":"57","author":"Snellman","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","article-title":"Effect of the apolipoprotein e genotype on cognitive change during a multidomain lifestyle intervention a subgroup analysis of a randomized clinical trial","volume":"75","author":"Solomon","year":"2018","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2023.106385_bb0150","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2023.106385_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neubiorev.2021.08.028","article-title":"Relationship between central obesity and the incidence of cognitive impairment and dementia from cohort studies involving 5,060,687 participants","volume":"130","author":"Tang","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.nbd.2023.106385_bb0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore longitudinal study of aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0165","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-190691","article-title":"Midlife insulin resistance as a predictor for late-life cognitive function and cerebrovascular lesions","volume":"72","author":"Toppala","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.nbd.2023.106385_bb0170","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1212\/WNL.0000000000011612","article-title":"Association of early \u03b2-amyloid accumulation and neuroinflammation measured with [(11)C]PBR28 in elderly individuals without dementia","volume":"96","author":"Toppala","year":"2021","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/brain\/awac354","article-title":"Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study","volume":"146","author":"van Arendonk","year":"2023","journal-title":"Brain."},{"issue":"7","key":"10.1016\/j.nbd.2023.106385_bb0180","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jamaneurol.2017.0323","article-title":"Linking amyloid-\u03b2 and tau deposition in Alzheimer disease","volume":"74","author":"Vemuri","year":"2017","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106385_bb0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"issue":"28","key":"10.1016\/j.nbd.2023.106385_bb0190","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}","volume":"284","author":"Zhao","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2023.106385_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123004011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123004011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:41:14Z","timestamp":1760852474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123004011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0969996123004011"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106385","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation \u2013 A 5-year follow-up [11C]PIB-PET study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106385"}}